-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
September 01, 2009 - Levels of cholesterol are
influenced by its production in the liver
and the ingestion of dietary fats … Known as statins, these agents
reduce the production of cholesterol in the liver by
binding with the … significant differences between treatments for the
outcomes of withdrawal due to adverse events and liver … In general, studies excluded participants
with statin-associated myopathy, deranged liver
enzymes, high … prerandomization run-in phase to minimize
nonadherence, and conducted frequent laboratory
monitoring for liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
March 01, 2011 - Liver injury
3. Congestive heart failure
4. Severe lactic acidosis
5. Cancer
6. … We also found little evidence regarding liver injury and
cancer, outcomes included in the 2007 evidence … Liver injury High The risk of liver injury was similar for thiazolidinediones and
sulfonylureas. … Moderate The rates of liver injury were similar between thiazolidinediones and
metformin.
15
Table
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/asymptomatic-bacteriuria-in-adults-screening
December 28, 2017 - Abbreviations: HELLP=hemolysis, elevated liver enzymes, low platelet count; RCT=randomized, controlled
-
digital.ahrq.gov/ahrq-funded-projects/improving-quality-through-health-information-technology-testing-feasibility-and/annual-summary/2009
January 01, 2009 - at 20 months post-implementation was evident on several measures, including CD4, lipid profile, and liver
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/lets-talk-about-it-aspirin-cvd-prevention-guide.pdf
April 26, 2022 - factors include male sex, diabetes, history of gastrointestinal issues (such as peptic
ulcer disease), liver
-
effectivehealthcare.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Severity.PDF
January 01, 2012 - comorbidity measure:
Hypothyroidism 7,296,968 0 0.00 1.00 0.10 0.29
CM_LIVER : AHRQ comorbidity measure: Liver … 50 Tuesday, May 20, 2014 5
Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
1: Liver … Other hepatobiliary, pancreas & abdominal procedures 2,016 0.03%
279: Hepatic coma & other major acute liver … disorders 19,940 0.27%
280: Alcoholic liver disease 12,554 0.17%
281: Malignancy of hepatobiliary … Frequency Distribution for APRDRG
APRDRG Frequency
Percent
of Total
283: Other disorders of the liver
-
psnet.ahrq.gov/web-mm/paradoxical-pulse
May 01, 2013 - within the therapeutic range), but a slightly elevated creatinine and a new transaminitis (elevated liver … not "look ill," or because their primary motivation to obtain the CT was to investigate his abnormal liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
January 01, 2017 - retention may occur with short-term use
Allopurinol �� Nausea, upset stomach, diarrhea, and elevated liver … and systemic symptoms (DRESS) syndrome
Febuxostat �� Abdominal pain, diarrhea, musculoskeletal pain, liver
-
psnet.ahrq.gov/web-mm/easily-forgotten-tube
June 01, 2016 - The Case
A 45-year-old man was admitted to the intensive care unit (ICU) for acute liver failure secondary … priorities for this patient were to treat the internal jugular deep vein thrombosis and to manage his liver
-
psnet.ahrq.gov/node/33592/psn-pdf
December 15, 2024 - He was found to have colon cancer with metastases to the liver.
-
effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research
-
hcup-us.ahrq.gov/db/nation/nis/reports/2012niscomparisonrpt.jsp
April 18, 2016 - Trach w mv 96+ hrs or pdx exc face, mouth & neck w/o maj O.R.
26,996
24,250
-10.2
5
Liver … transplant w mcc or intestinal transplant
1,268
1,120
-11.7
6
Liver transplant w/o mcc … & shunt
procedures w mcc
5,854
5,890
0.6
406
Pancreas, liver & shunt
procedures w … cc
7,060
6,710
-5.0
407
Pancreas, liver & shunt procedures w/o cc/mcc
2,788
2,605 … ,cirr,alc hepa w cc
27,949
26,865
-3.9
443
Disorders of liver except
malig,cirr,alc hepa
-
hcup-us.ahrq.gov/reports/methods/2015-04.pdf
January 01, 2015 - transplant w mcc or intestinal transplant 1,268 1,120 -11.7
6 Liver transplant w/o mcc 410 380 -7.3 … & shunt procedures w mcc 5,854 5,890 0.6
406 Pancreas, liver & shunt procedures w cc 7,060 6,710 - … 5.0
407 Pancreas, liver & shunt procedures w/o cc/mcc 2,788 2,605 -6.6
408 Biliary tract proc except … except malig,cirr,alc hepa w mcc 25,140 25,205 0.3
442 Disorders of liver except malig,cirr,alc hepa … w cc 27,949 26,865 -3.9
443 Disorders of liver except malig,cirr,alc hepa w/o cc/mcc 6,318 6,320 0.0
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2017_IP_MaskedStats.PDF
January 01, 2017 - MAJ O.R. 8,098 0.17
4: TRACH W MV >96 HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. 6,877 0.15
5: LIVER … TRANSPLANT W MCC OR INTESTINAL TRANSPLANT 170 0.00
6: LIVER TRANSPLANT W/O MCC 16 0.00
7: LUNG TRANSPLANT … , LIVER & SHUNT PROCEDURES W/O CC/MCC 89 0.00
408: BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/O … EXCEPT MALIG,CIRR,ALC HEPA W MCC 9,982 0.21
442: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC … 11,769 0.25
443: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W/O CC/MCC 3,238 0.07
444: DISORDERS
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/o6pGCffkVCx24mNebJGCXg
January 01, 2013 - , in-
cluding cirrhosis, liver failure, hepatocellular carcinoma,
and death (1, 2). … Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for
the Study of Liver Diseases. … Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the
Study of Liver Diseases. … Liver Int. 2011;31:401-11. [PMID: 21281434]
26. Khan A, Awan A, Shahbuddin S, Iqbal Q. … J Gastrointestin Liver Dis. 2006;15:213-9.
[PMID: 17013444]
55.
-
hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comformat_icd10cm_2020_1.txt
January 01, 2020 - "K7469",
"K754",
"K7581",
"K760",
"K766",
"K7689",
"K769",
"Z944"="LIVER … " /*Liver disease*/
"C8100",
"C8101",
"C8102",
"C8103",
"C8104",
" … Kidney transp, renal fail/dialysis */
652, 682-684 = "YES" ;
VALUE LIVERDRG /* Liver
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_IP_MaskedStats.PDF
January 01, 2019 - , LIVER & SHUNT PROCEDURES W/O CC/MCC 65 0.00
408: BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/O … EXCEPT MALIG, CIRR, ALC HEPA W MCC 2,937 0.06
441: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W … MCC 8,804 0.19
442: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC HEPA W CC 3,016 0.06
442: DISORDERS … OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC 9,526 0.20
443: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC … OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC 9,528 0.20
443: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_CORE.PDF
January 01, 2020 - 960 0.01%
6: LIVER TRANSPLANT W/O MCC 769 0.00%
6: LIVER TRANSPLANT WITHOUT MCC 296 0.00%
7: LUNG … & SHUNT PROCEDURES W MCC 5,441 0.03%
405: PANCREAS, LIVER AND SHUNT PROCEDURES WITH MCC 1,899 0.01% … 406: PANCREAS, LIVER & SHUNT PROCEDURES W CC 6,852 0.04%
406: PANCREAS, LIVER AND SHUNT PROCEDURES … WITH CC 2,372 0.01%
407: PANCREAS, LIVER & SHUNT PROCEDURES W/O CC/MCC 2,795 0.02%
407: PANCREAS, … LIVER AND SHUNT PROCEDURES WITHOUT CC/MCC 983 0.01%
408: BILIARY TRACT PROC EXC ONLY CHOLECYSTECTOMY
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_Core_Weighted.PDF
January 01, 2020 - 1,811 0.01%
6: LIVER TRANSPLANT W/O MCC 1,448 0.00%
6: LIVER TRANSPLANT WITHOUT MCC 563 0.00%
7: … & SHUNT PROCEDURES W MCC 9,745 0.03%
405: PANCREAS, LIVER AND SHUNT PROCEDURES WITH MCC 3,377 0.01% … 406: PANCREAS, LIVER & SHUNT PROCEDURES W CC 12,336 0.04%
406: PANCREAS, LIVER AND SHUNT PROCEDURES … WITH CC 4,175 0.01%
407: PANCREAS, LIVER & SHUNT PROCEDURES W/O CC/MCC 4,969 0.02%
407: PANCREAS, … OR ALCOHOLIC HEPATITIS WITH
MCC
15,121 0.05%
442: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC HEPA